Market Value3,126,999,740
Total Holdings73
File Date2026-02-17
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ARGX / argenx SE - Depositary Receipt (Common Stock)
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
ILMN / Illumina, Inc.
US64049MAB63 / NeoGenomics Inc
NBIX / Neurocrine Biosciences, Inc.
KOD / Kodiak Sciences Inc.
GKOS / Glaukos Corporation
RGEN / Repligen Corporation
SYRE / Spyre Therapeutics, Inc.
TMDX / TransMedics Group, Inc.
DHR / Danaher Corporation
INSP / Inspire Medical Systems, Inc.
MBX / MBX Biosciences, Inc.
ISRG / Intuitive Surgical, Inc.
CDNA / CareDx, Inc.
BTSG / BrightSpring Health Services, Inc.
FULC / Fulcrum Therapeutics, Inc.
CGON / CG Oncology, Inc.
KRYS / Krystal Biotech, Inc.
NTRA / Natera, Inc.
NEO / NeoGenomics, Inc.
DNTH / Dianthus Therapeutics, Inc.
CAI / Caris Life Sciences, Inc.
APGE / Apogee Therapeutics, Inc.
EHC / Encompass Health Corporation
ACAD / ACADIA Pharmaceuticals Inc.
ADPT / Adaptive Biotechnologies Corporation
ALGN / Align Technology, Inc.
BLLN / BillionToOne, Inc.
BIIB / Biogen Inc.
CSTL / Castle Biosciences, Inc.
CLDX / Celldex Therapeutics, Inc.
CMPX / Compass Therapeutics, Inc.
DYN / Dyne Therapeutics, Inc.
ENGN / enGene Therapeutics Inc.
GUARDANT HEALTH INC / DEBT 1.250% 2/1 (40131MAD1)
ICLR / ICON Public Limited Company
IRTC / iRhythm Holdings, Inc.
IRHYTHM TECHNOLOGIES INC / NOTE 1.500% 9/0 (450056AB2)
US46333XAH17 / CONV. NOTE
KYMR / Kymera Therapeutics, Inc.
ORKA / Oruka Therapeutics, Inc.
NUVL / Nuvalent, Inc.
RAPT / RAPT Therapeutics, Inc.
RLMD / Relmada Therapeutics, Inc.
REPLIGEN CORP / NOTE 1.000%12/1 (759916AD1)
TECX / Tectonic Therapeutic, Inc.
TERN / Terns Pharmaceuticals, Inc.
XFOR / X4 Pharmaceuticals, Inc.
XNCR / Xencor, Inc.
AKRO / Akero Therapeutics, Inc.
CVS / CVS Health Corporation
GMED / Globus Medical, Inc.
THC / Tenet Healthcare Corporation
RNA / Atrium Therapeutics, Inc.
VKTX / Viking Therapeutics, Inc.
AMLX / Amylyx Pharmaceuticals, Inc.
EXAS / Exact Sciences Corporation
RPRX / Royalty Pharma plc
DAWN / Day One Biopharmaceuticals, Inc.
SION / Sionna Therapeutics, Inc.
HTFL / HeartFlow, Inc.
REPL / Replimune Group, Inc.
SRPT / Sarepta Therapeutics, Inc.
RARE / Ultragenyx Pharmaceutical Inc.
LUNG / Pulmonx Corporation
GLUE / Monte Rosa Therapeutics, Inc.
XENE / Xenon Pharmaceuticals Inc.
ZURA / Zura Bio Limited
VTYX / Ventyx Biosciences, Inc.
HNGE / Hinge Health, Inc.
KPTI / Karyopharm Therapeutics Inc.
SRZN / Surrozen, Inc.
EWTX / Edgewise Therapeutics, Inc.
HROW / Harrow, Inc.
EOLS / Evolus, Inc.
MRVI / Maravai LifeSciences Holdings, Inc.
SLNO / Soleno Therapeutics, Inc.
KIDS / OrthoPediatrics Corp.
BMRN / BioMarin Pharmaceutical Inc.
PEN / Penumbra, Inc.
VERA / Vera Therapeutics, Inc.
TMO / Thermo Fisher Scientific Inc.
KNSA / Kiniksa Pharmaceuticals International, plc
DRUG / Bright Minds Biosciences Inc.
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
GRAL / GRAIL, Inc.
NRIX / Nurix Therapeutics, Inc.
ATEC / Alphatec Holdings, Inc.